Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04681352 · ClinicalTrials.gov registry record · NA
A Study of Octave System for Improving Lines and Wrinkles of the Décolleté
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT04681352: Completed NA study, sponsored by Merz North America.
NCT04681352 is a NA study that has completed, run by Merz North America. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04681352, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.
Primary Outcome
Improvement in lines and wrinkles of the décolleté were determined after comparing Day 90 photographs with baseline photographs. Improvement was concluded if at least two evaluators assessed the Day 90 photographs as "improved" compared to baseline.
Interventions
- DEVICE Octave-Ultherapy treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2022-02-21 |
| Phase | NA |
What the finished NCT04681352 record still lists
NCT04681352 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Octave-Ultherapy treatment is the first listed.
NCT04681352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04681352 about?
NCT04681352 is a clinical study titled "A Study of Octave System for Improving Lines and Wrinkles of the Décolleté". To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.
What is the current status of trial NCT04681352?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2020-12-29. Estimated completion is 2022-02-21.
What interventions are being tested in trial NCT04681352?
The interventions under investigation include: Octave-Ultherapy treatment (DEVICE).
Who is sponsoring clinical trial NCT04681352?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04681352's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI